UA72789C2 - Heterocyclic amide derivatives - Google Patents

Heterocyclic amide derivatives Download PDF

Info

Publication number
UA72789C2
UA72789C2 UA2002086471A UA2002086471A UA72789C2 UA 72789 C2 UA72789 C2 UA 72789C2 UA 2002086471 A UA2002086471 A UA 2002086471A UA 2002086471 A UA2002086471 A UA 2002086471A UA 72789 C2 UA72789 C2 UA 72789C2
Authority
UA
Ukraine
Prior art keywords
alkyl
optionally substituted
hydroxy
compound according
differs
Prior art date
Application number
UA2002086471A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UA72789C2 publication Critical patent/UA72789C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
UA2002086471A 2000-02-04 2001-01-26 Heterocyclic amide derivatives UA72789C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18015900P 2000-02-04 2000-02-04
PCT/IB2001/000107 WO2001057023A1 (fr) 2000-02-04 2001-01-26 Derives de l'amide heterocyclique

Publications (1)

Publication Number Publication Date
UA72789C2 true UA72789C2 (en) 2005-04-15

Family

ID=22659425

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002086471A UA72789C2 (en) 2000-02-04 2001-01-26 Heterocyclic amide derivatives

Country Status (38)

Country Link
US (2) US6548671B2 (fr)
EP (1) EP1252154A1 (fr)
JP (1) JP2003522164A (fr)
KR (2) KR20050009776A (fr)
CN (1) CN1398265A (fr)
AP (1) AP2002002595A0 (fr)
AR (1) AR027349A1 (fr)
AU (1) AU2699701A (fr)
BG (1) BG106922A (fr)
BR (1) BR0108002A (fr)
CA (1) CA2399214A1 (fr)
CZ (1) CZ20022542A3 (fr)
EA (2) EA200401099A1 (fr)
EE (1) EE200200432A (fr)
GE (1) GEP20043301B (fr)
GT (1) GT200100021A (fr)
HK (1) HK1050006A1 (fr)
HN (1) HN2001000021A (fr)
HR (1) HRP20020638A2 (fr)
HU (1) HUP0204560A3 (fr)
IL (1) IL150862A0 (fr)
IS (1) IS6468A (fr)
MA (1) MA25653A1 (fr)
NO (1) NO20023675L (fr)
NZ (1) NZ520075A (fr)
OA (1) OA12174A (fr)
PA (1) PA8511401A1 (fr)
PE (1) PE20011057A1 (fr)
PL (1) PL357094A1 (fr)
PY (1) PY0102270A (fr)
SK (1) SK10882002A3 (fr)
SV (1) SV2002000302A (fr)
TN (1) TNSN01021A1 (fr)
TW (1) TW200804311A (fr)
UA (1) UA72789C2 (fr)
UY (1) UY26568A1 (fr)
WO (1) WO2001057023A1 (fr)
ZA (1) ZA200206140B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002347985A1 (en) * 2001-11-15 2003-06-10 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
SE0201980D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
AU2006315436A1 (en) 2005-11-15 2007-05-24 Vertex Pharmaceuticals Incorporated Azaindazoles useful as inhibitors of kinases
CN1971279B (zh) * 2006-12-06 2011-05-18 华中农业大学 喹噁啉-2-羧酸残留的酶联免疫检测方法及试剂盒
AU2018235561B2 (en) 2017-03-13 2020-06-18 Asahi Kasei Pharma Corporation Tetrahydroquinoline derivatives as P2X7 receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88619A0 (en) * 1987-12-15 1989-07-31 Pfizer Non-peptidic renin inhibitors
EP0374098A3 (fr) * 1988-12-15 1991-05-02 Ciba-Geigy Ag Inhibiteurs de protéase rétrovirale
ZA926933B (en) 1991-09-11 1994-03-09 Smithkline Beecham Corp Peptide isosteres containing a heterocycle
EP0628035A4 (fr) * 1992-02-26 1995-03-29 Smithkline Beecham Corp Inhibiteurs de la protease retrovirale.
DE69527405T2 (de) * 1994-10-19 2003-03-13 Novartis Ag, Basel Antivirale Ether von Aspartat-Protease-Substrat-Isosteren
SK112899A3 (en) * 1997-02-26 2001-05-10 Pfizer Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
ATE337307T1 (de) * 1998-02-05 2006-09-15 Pfizer Prod Inc Neue dihydroxyhexansäurederivate

Also Published As

Publication number Publication date
GT200100021A (es) 2001-01-31
TNSN01021A1 (fr) 2005-11-10
AR027349A1 (es) 2003-03-26
KR20020072304A (ko) 2002-09-14
CZ20022542A3 (cs) 2003-08-13
EA200401099A1 (ru) 2005-02-24
KR20050009776A (ko) 2005-01-25
EA200200749A1 (ru) 2002-12-26
US20020132810A1 (en) 2002-09-19
WO2001057023A1 (fr) 2001-08-09
PE20011057A1 (es) 2001-10-22
SV2002000302A (es) 2002-07-16
US6689886B2 (en) 2004-02-10
CA2399214A1 (fr) 2001-08-09
HN2001000021A (es) 2001-07-08
BG106922A (bg) 2003-03-31
HUP0204560A3 (en) 2005-03-29
UY26568A1 (es) 2001-08-27
NO20023675D0 (no) 2002-08-02
AU2699701A (en) 2001-08-14
IL150862A0 (en) 2003-02-12
JP2003522164A (ja) 2003-07-22
TW200804311A (en) 2008-01-16
CN1398265A (zh) 2003-02-19
NO20023675L (no) 2002-09-10
OA12174A (en) 2006-05-09
MA25653A1 (fr) 2002-12-31
SK10882002A3 (sk) 2003-10-07
BR0108002A (pt) 2002-10-29
PY0102270A (es) 2003-10-01
PA8511401A1 (es) 2002-09-17
ZA200206140B (en) 2003-08-01
IS6468A (is) 2002-07-11
US20030204086A1 (en) 2003-10-30
HRP20020638A2 (en) 2004-12-31
EE200200432A (et) 2003-12-15
US6548671B2 (en) 2003-04-15
PL357094A1 (pl) 2004-07-12
HK1050006A1 (zh) 2003-06-06
EP1252154A1 (fr) 2002-10-30
HUP0204560A2 (en) 2003-05-28
GEP20043301B (en) 2004-02-10
NZ520075A (en) 2004-02-27
EA005320B1 (ru) 2005-02-24
AP2002002595A0 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
KR102034618B1 (ko) Dna 알킬화제
US20230026909A1 (en) 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors
US20230115107A1 (en) Novel spiropyrrolidine derived antiviral agents
JP2005514398A (ja) Ｉｍｐｄｈ酵素のヘテロ環アクリドンインヒビター
JP2006528677A (ja) ジャイレース阻害剤およびその用途
CN102131800A (zh) 5元和6元杂环化合物
JP2006528677A5 (fr)
EP3876928B1 (fr) Inhibiteurs de désacétylase d'histone utiles pour traiter ou prévenir une infection par le vih
EP0702004A2 (fr) Dérivés d'amides d'acide 2,9-diamino- et 2-amino-2-carbamoyl-4-hydroxy-alcanoiques
TWI386402B (zh) Ｎ-（雜芳基）-１-雜芳基烷基-１ｈ-吲哚-２-甲醯胺衍生物，其製備方法及其治療用途
CN114206868A (zh) 作为hdac6抑制剂的3-(2-(杂芳基)-吡啶-4-基)-5-(三氟甲基)-1,2,4-噁二唑衍生物
HUP0100832A2 (hu) Kinoxalin- és kinolin-karbonsavamid-származékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
CA1337072C (fr) [4,5-c] imidazopyridines a substituant en 5
WO2004020584A2 (fr) Antagonistes des recepteurs des chimiokines
CN87107723A (zh) 二氢吡啶抗变应性剂和抗炎性剂
US6689886B2 (en) Quinoxalinyl carboxylic acid derivatives
JP2008542410A (ja) リパーゼ及びホスホリパーゼ阻害剤としてのアゾロピリジン−２−オン誘導体
JP2008542412A (ja) リパーゼ及びホスホリパーゼ阻害剤としてのベンゾオキサゾール−２−オン誘導体
JP2008542411A (ja) リパーゼ及びホスホリパーゼ阻害剤としてのベンゾチアゾール−２−オン誘導体
US20040087571A1 (en) Methods of using CCR1 antagonists as immunomodulatory agents
EP1498417A1 (fr) Amides hétérocycliques
JP2005527604A (ja) ジヒドロフラン２オン誘導体の製造方法
BR112020010534B1 (pt) Derivados de 1,2,4-oxadiazol, seus usos como inibidores de histona desacetilase 6 e composição farmacêutica compreendendo os mesmos